Skip to main content
Experience the Future of Rheumatology at RheumNow Live 2024, less than three weeks away!

Don't miss out – secure you

Dr. John Cush RheumNow

2 years 9 months ago
Experience the Future of Rheumatology at RheumNow Live 2024, less than three weeks away! Don't miss out – secure your spot today for an unforgettable journey into the latest advancements and insights. https://t.co/7VIOmAJxWn https://t.co/DPhTz7Sqph
Study of 233 early #RA (<12 mo) (n = 233) showed baseline Dz activity didnt predict later #CVD (n 70) & #CAD

Dr. John Cush RheumNow

2 years 9 months ago
Study of 233 early #RA (<12 mo) (n = 233) showed baseline Dz activity didnt predict later #CVD (n 70) & #CAD (52), But at 2 yrs, ESR, CRP & DAS28 > 5.1 predicted incr risk CVD [adj HR 2.58) & CAD events. COMP did not predict. https://t.co/bH9Cylmy4f https://t.co/66PVC6f01a
Last Friday, the Food and Drug Administration (FDA) approved Florida’s plan to import certain prescription drugs directly from Canada.  Florida is the first time a state to undertake this pathway to save money.
A Swedish study examine the genetic contribution to various rheumatic/musculoskeletal diseases (RMDs) and showed that osteoarthritis (OA) had a large heritability compared with other RMDs.
Life expectancy in RA? Taiwan insurance claims data shows life expectancy after an RA Dx was 26.3 yrs, w/ mean loss of

Dr. John Cush RheumNow

2 years 9 months ago
Life expectancy in RA? Taiwan insurance claims data shows life expectancy after an RA Dx was 26.3 yrs, w/ mean loss of 5 yrs. Women lived 1–2 yrs longer than men. https://t.co/Z5PqWZX94V https://t.co/RKZNDxPUd3
Curcumin therapy for knee osteoarthritis

Curcumin is widely used in traditional Chinese medicine to treat arthritis an

Dr. John Cush RheumNow

2 years 9 months ago
Curcumin therapy for knee osteoarthritis Curcumin is widely used in traditional Chinese medicine to treat arthritis and is presumed to have analgesic and antiinflammatory effects that may benefit those with osteoarthritis, particularly KOA. https://t.co/0EmPrEZTce https://t.co/74uNQJ3a34
Enthesitis, Synovitis, and Tenosynovitis in Psoriatic Arthritis

An ultrasound study suggests that enthesitis is associ

Dr. John Cush RheumNow

2 years 9 months ago
Enthesitis, Synovitis, and Tenosynovitis in Psoriatic Arthritis An ultrasound study suggests that enthesitis is associated with both synovitis and tenosynovitis in patients with Psoriatic arthritis (PsA). https://t.co/fsVlUwOXCW https://t.co/1tLTlEoXd8
Experience the Future of Rheumatology at RheumNow Live 2024, just three weeks away!

Don't miss out – secure your spo

Dr. John Cush RheumNow

2 years 9 months ago
Experience the Future of Rheumatology at RheumNow Live 2024, just three weeks away! Don't miss out – secure your spot today for an unforgettable journey into the latest advancements and insights. https://t.co/HN8ErCpSMb https://t.co/kCYD7Hbhxx
Hydroxychloroquine for COVID may have caused 16,990 deaths. Systematic review of 44 cohort studies showed HCQ use in COV

Dr. John Cush RheumNow

2 years 9 months ago
Hydroxychloroquine for COVID may have caused 16,990 deaths. Systematic review of 44 cohort studies showed HCQ use in COVID was associated with 11% increase in mortality in 6 countries (US 12,739, Spain 1,895, Italy 1,822, Belgium 240, France 199,Turkey 95 https://t.co/vmhvSx4XLO https://t.co/KRxqiiSFC3
There is a dose, duration and recency-dependent relationship between previous GC use and MACE. GC doses 5mg/day, duratio

Dr. John Cush RheumNow

2 years 9 months ago
There is a dose, duration and recency-dependent relationship between previous GC use and MACE. GC doses 5mg/day, durations of 30 days, and use one year prior to MACE were all associated with an increased risk of MACE, Wallace B Abst#2430 #ACR23 #ACRBest https://t.co/VOUmsvAs2r https://t.co/LKtuuoD3xa
Biomarker Predicts Survival in Autoimmune Lung Disease

One major subgroup of patients with ILD arising from polymyosit

Dr. John Cush RheumNow

2 years 9 months ago
Biomarker Predicts Survival in Autoimmune Lung Disease One major subgroup of patients with ILD arising from polymyositis/dermatomyositis (PM/DM) survived significantly longer when serum levels of interferon-λ3 were relatively low, researchers found. https://t.co/2nYPBbNfCh https://t.co/n2Llxb7tdx
Anti-TNF mAbs, JAKi & anti-IL17 Rx appear protective against anterior Uveitis in AxSpA pts. Network Metanalysis of 4

Dr. John Cush RheumNow

2 years 9 months ago
Anti-TNF mAbs, JAKi & anti-IL17 Rx appear protective against anterior Uveitis in AxSpA pts. Network Metanalysis of 44 trials, AU IR -TNF mAb: 4.1, ETN: 5.4, IL17i: 2.8, JAKi: 1.5, & placebo: 10.8. AU risk: TNFi < JAKi < IL-17i < ETN << PBO https://t.co/3zIcvuIaBV https://t.co/UseZ6t00EB
×